Zimmer Biomet Holdings Revenue 2006-2018 | ZBH

Zimmer Biomet Holdings annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Zimmer Biomet Holdings revenue for the quarter ending December 31, 2018 was $2.071B, a 0.13% increase year-over-year.
  • Zimmer Biomet Holdings revenue for the twelve months ending December 31, 2018 was $7.933B, a 1.66% increase year-over-year.
  • Zimmer Biomet Holdings annual revenue for 2018 was $7.933B, a 1.66% increase from 2017.
  • Zimmer Biomet Holdings annual revenue for 2017 was $7.803B, a 1.76% increase from 2016.
  • Zimmer Biomet Holdings annual revenue for 2016 was $7.668B, a 27.85% increase from 2015.
Zimmer Biomet Holdings Annual Revenue
(Millions of US $)
2018 $7,933
2017 $7,803
2016 $7,668
2015 $5,998
2014 $4,673
2013 $4,623
2012 $4,472
2011 $4,452
2010 $4,220
2009 $4,095
2008 $4,121
2007 $3,898
2006 $3,495
2005 $3,286
Zimmer Biomet Holdings Quarterly Revenue
(Millions of US $)
Q4 2018 $2,071
Q3 2018 $1,837
Q2 2018 $2,008
Q1 2018 $2,018
Q4 2017 $2,068
Q3 2017 $1,813
Q2 2017 $1,950
Q1 2017 $1,972
Q4 2016 $1,998
Q3 2016 $1,833
Q2 2016 $1,934
Q1 2016 $1,904
Q4 2015 $1,934
Q3 2015 $1,762
Q2 2015 $1,168
Q1 2015 $1,134
Q4 2014 $1,223
Q3 2014 $1,106
Q2 2014 $1,183
Q1 2014 $1,162
Q4 2013 $1,241
Q3 2013 $1,074
Q2 2013 $1,170
Q1 2013 $1,139
Q4 2012 $1,181
Q3 2012 $1,026
Q2 2012 $1,125
Q1 2012 $1,141
Q4 2011 $1,167
Q3 2011 $1,032
Q2 2011 $1,137
Q1 2011 $1,116
Q4 2010 $1,135
Q3 2010 $965
Q2 2010 $1,058
Q1 2010 $1,063
Q4 2009 $1,107
Q3 2009 $976
Q2 2009 $1,020
Q1 2009 $993
Q4 2008 $1,030
Q3 2008 $952
Q2 2008 $1,080
Q1 2008 $1,059
Q4 2007 $1,074
Q3 2007 $903
Q2 2007 $971
Q1 2007 $950
Q4 2006 $934
Q3 2006 $820
Q2 2006 $882
Q1 2006 $860
Q4 2005 $848
Q3 2005 $763
Q2 2005 $847
Q1 2005 $829
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.620B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14